Adolescent Medicine News

Teens and young adults who used cannabis had lower grades and school attendance and were less likely to complete high school or college compared with their peers who did not use cannabis, according to recent findings.

In this episode, host Hansa Bhargava, MD, discusses opioid awareness, the stigma surrounding the opioid crisis and the resources for intervention with David A. Fiellin, MD.

ORLANDO — The AAP on Monday released its first clinical guidance for prescribing opioids to children, which supports prescribing opioids when necessary and safe — although not as monotherapy and not without also providing naloxone.

Cost, discomfort with self-administration and privacy concerns are potential barriers to increasing the use of STI self-tests among adolescents and young adults, according to a study.

The FDA has approved Aqneursa as an oral treatment for neurological symptoms associated with Niemann-Pick disease type C, a rare genetic disease, in adults and children weighing at least 15 kg, according to a press release.

Although screen use before bedtime did not affect sleep onset or duration in children, using screens in bed not only impacted sleep quality but was also associated with cyberbullying and psychological distress, research showed.

The FDA announced in a press release that it has approved Miplyffa to treat neurological symptoms associated with Niemann-Pick disease type C in patients aged 2 years and older.

Intermittent and continuous energy restriction diets both improved cardiometabolic measures and reduced symptoms of depression and disordered eating among adolescents with obesity, according to findings published in JAMA Pediatrics.

Owning and playing on game consoles during the COVID-19 pandemic improved mental health among Japanese children and adults, according to findings published in Nature Human Behavior.